| |
| |
|
| Insider
Information: |
Merriweather Alfred G |
| Relationship: |
Chief Financial Officer |
| City: |
Mountain View |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
58,062 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$440,211 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
58,062 |
|
|
| Total
Value |
$440,211 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Monogram Biosciences Inc |
134495-OLD |
Officer |
2004-12-16 |
10,043 |
|
0 |
Premium* |
|
|
Adamas Pharmaceuticals Inc |
ADMS |
Chief Financial Officer |
2019-09-20 |
48,019 |
2017-07-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
7 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADMS |
Adamas Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2019-09-20 |
4 |
S |
$6.91 |
$10,945 |
D/D |
(1,584) |
48,019 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2019-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
49,603 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2019-03-20 |
4 |
S |
$7.99 |
$6,847 |
D/D |
(857) |
24,603 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2018-09-21 |
4 |
S |
$19.18 |
$31,935 |
D/D |
(1,665) |
25,460 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2018-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
8,375 |
27,125 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2017-07-10 |
4 |
A |
$0.00 |
$0 |
D/D |
18,750 |
18,750 |
0 |
- |
|
| 134495-OLD |
Monogram Biosciences Inc |
Chief Financial OfficerOfficer |
• – – |
2004-12-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,043 |
|
- |
|
7 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
